Avalon Globocare (OTCMKTS:AVCO) and Pharma Bio Serv (OTCMKTS:PBSV) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.
Valuation and Earnings
This table compares Avalon Globocare and Pharma Bio Serv’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Avalon Globocare||$1.08 million||319.95||-$3.46 million||N/A||N/A|
|Pharma Bio Serv||$17.79 million||1.35||$1.27 million||N/A||N/A|
Pharma Bio Serv has higher revenue and earnings than Avalon Globocare.
Pharma Bio Serv pays an annual dividend of $0.08 per share and has a dividend yield of 7.8%. Avalon Globocare does not pay a dividend.
Volatility and Risk
Avalon Globocare has a beta of -2.03, indicating that its share price is 303% less volatile than the S&P 500. Comparatively, Pharma Bio Serv has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500.
This is a summary of recent ratings for Avalon Globocare and Pharma Bio Serv, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Pharma Bio Serv||0||0||0||0||N/A|
This table compares Avalon Globocare and Pharma Bio Serv’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Pharma Bio Serv||7.07%||7.61%||6.11%|
Pharma Bio Serv beats Avalon Globocare on 7 of the 8 factors compared between the two stocks.
Avalon Globocare Company Profile
Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology, as well as rehabilitation medicine. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products to hospitals, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.
Pharma Bio Serv Company Profile
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Receive News & Ratings for Avalon Globocare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon Globocare and related companies with MarketBeat.com's FREE daily email newsletter.